FDA
- Status: approved
🇺🇸 Dupilumab therapy in United States
Dupilumab therapy (Dupilumab therapy) regulatory status in United States.
Marketing authorisation
Dupilumab therapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Dupilumab therapy approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Dupilumab therapy in United States?
National Medical Research Center for Children's Health, Russian Federation is the originator. The local marketing authorisation holder may differ — check the official source linked above.